tiprankstipranks
Natera Acquires Invitae’s Prenatal Screening Business
Market News

Natera Acquires Invitae’s Prenatal Screening Business

Natera (NTRA) has released an update.

Don't Miss our Black Friday Offers:

Natera, Inc. announced the acquisition of assets related to Invitae Corporation’s non-invasive prenatal screening and genetic carrier screening business on January 22, 2024. A press release detailing the acquisition was filed with the relevant regulatory documents.

For further insights into NTRA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyNatera price target raised to $200 from $150 at Piper Sandler
TheFlyNatera price target raised to $176 from $132 at Morgan Stanley
TheFlyNatera price target raised to $157 from $121 at Craig-Hallum
Go Ad-Free with Our App